Nuvation Bio Inc.
NUVB | NYSE
$6.07
+$0.22 (+3.76%)
At close: Sep 21, 2026, 4:00 PM ET
$6.08
+$0.01 (+0.16%)
Pre-market:
Sep 22, 2026, 4:25 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 62.9M | 7.87M | n/a | n/a | n/a | n/a |
Cost of Revenue | 8.44M | 7.08M | n/a | n/a | n/a | 103K |
Gross Profit | 54.46M | 795K | n/a | n/a | n/a | -103K |
Operating Income | -213.06M | -592.63M | -99.82M | -119.73M | -93.32M | -43.55M |
Interest Income | 21.43M | 27.06M | 24.61M | 7.45M | 2.96M | 1.95M |
Pretax Income | -204.63M | -567.94M | -75.8M | -104.2M | -86.85M | -41.66M |
Net Income | -204.63M | -567.94M | -75.8M | -104.2M | -86.85M | -41.66M |
Selling & General & Admin | 151.56M | 69.23M | 28.53M | 31.92M | 24.28M | 10.85M |
Research & Development | 115.11M | 524.19M | 71.29M | 87.82M | 69.04M | 32.6M |
Other Expenses | 856K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 267.52M | 593.42M | 99.82M | 119.73M | 93.32M | 43.45M |
Interest Expense | 13.68M | 341K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 2.5M | n/a | n/a | n/a | n/a |
Cost & Expenses | 275.97M | 600.5M | 99.82M | 119.73M | 93.32M | 43.55M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 341.54M | 268.77M | 218.88M | 216.72M | 197.89M | 217.65M |
Shares Outstanding (Diluted) | 341.54M | 268.77M | 218.88M | 216.72M | 197.89M | 217.65M |
EPS (Basic) | -0.60 | -2.11 | -0.35 | -0.48 | -0.44 | -0.19 |
EPS (Diluted) | -0.60 | -2.11 | -0.35 | -0.48 | -0.44 | -0.19 |
EBITDA | -189.21M | -566.92M | -75.58M | -104M | -86.66M | -41.56M |
EBIT | -190.95M | -567.6M | -75.8M | -104.2M | -86.85M | -41.66M |
Depreciation & Amortization | 1.74M | 683K | 222K | 199K | 184K | 103K |
Add to Watchlist
Select watchlists to add or remove NUVB